The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.
Bloomberg
A coronavirus vaccine from a unit of Johnson & Johnson was expected to move to the third phase of clinical trials in the UK on Monday that will test safety and effectiveness of the shot.
The testing round by Janssen Pharmaceutical Companies will include 6,000 volunteers and take place across 17 sites, according to a statement. The vaccine is the third candidate to be tested in the UK, alongside one from an AstraZeneca in partnership with the University of Oxford and another from Novavax Inc, it said.
Progress toward creating vaccines against Covid-19 has accelerated this month, with Pfizer Inc and BioNTech SE saying their shot prevented more than 90% of symptomatic infections in a trial.
Still, hurdles for production and development remain before vaccines could reach widespread use.